Govt Job: For Pharmacy Graduates at Indian Institute of Technology

The Indian School of Mines was formally established on December 9th, 1926, by Lord Irwin, the Viceroy of India at the time, to address the demand for mining-related trained labor in the nation. The school offers programs in mining and applied geology.

In 1967 it was granted the status of a deemed to be university under Section 3 of the UGC Act, 1956. Since its establishment, IIT(ISM) has undergone considerable expansion of its activities, and presently it can be considered a total technology education institute.

Post : Project Assistant (PA)

Applications are invited under the sponsored project and the details are given below.

Project: Improving the Economic Well-Being of Scheduled Tribe Communities (ST) Using Game Theoretic and Operations Research Techniques in the Jamtara District of Jharkhand State.

Sponsoring Agency: DST (SEED Division), GoI
Principal InvestigatorProf. Rashmi Singh

Essential Qualification
• Graduation in Engineering/Technology/Medicine/Pharma or graduation in Science from a leading institute with a good track record

• At least one year of working experience (mandatory) in prominent roles for handling statistical analysis and related activities is essential.

Age limit: Preferably below 35 years (Relaxation as per GoI norms)

Job Description

• Data collection using primary survey and data analytics

• Documentation and report preparation.

• Development of optimization model

• Handling the project management aspect for this project• Keeping a record of inflows and outflows in this project

• The Project Assistant will report to the investigators of the project

Tenure of Post: For three years or based on the end date of the project whichever is earlier

Salary: Rs. 22000/-per month (consolidated)

• The candidates are required to submit a copy of their detailed resume with their photograph and enclose all relevant supporting documents regarding age, qualification, and experience through email rashmis@iitism.ac.in within the due date.

•  The candidates are also required to bring the original certificates and supporting documents for verification at the time of joining. For further details, candidates may contact Dr. Rashmi Singh, Principal Investigator, IIT (ISM) Dhanbad rashmis@iitism.ac.in

• Shortlisted candidates will be informed of the date of the interview. Mere possession of minimum qualification does not guarantee an invitation to the interview.

candidates will be short-listed based on their merit and as per the requirement of the project. All candidates should make their own arrangements for their stay at Dhanbad if required.

No TA/DA will be paid to attend the interview.

Sanction No. : DST/SEED/TSP/STI/2020/337/G

Last Date & Time: August 30th, 2022, 5:00 P.M.

Related Posts

AbbVie loses patent plea for Hep C drug

New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…

GSK’s Calpol a well-known trademark: High Court

New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer